<i>In vivo</i> genome‐editing screen identifies tumor suppressor genes that cooperate with <i>Trp53</i> loss during mammary tumorigenesis-Reference-Cited by-同舟云学术

In vivo genome‐editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis

Published:2022-01-26 Issue:5 Volume:16 Page:1119-1131
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Heitink Luuk¹²,Whittle James R.¹²³,Vaillant François¹²,Capaldo Bianca D.¹²,Dekkers Johanna F.¹⁴,Dawson Caleb A.¹²⁵,Milevskiy Michael J. G.¹²,Surgenor Elliot¹,Tsai Minhsuang¹,Chen Huei‐Rong¹,Christie Michael⁶⁷,Chen Yunshun²⁸,Smyth Gordon K.⁸⁹^ORCID,Herold Marco J.²¹⁰,Strasser Andreas²¹⁰,Lindeman Geoffrey J.¹²³^ORCID,Visvader Jane E.¹²^ORCID

Affiliation:

1. ACRF Cancer Biology and Stem Cells Division The Walter and Eliza Hall Institute of Medical Research Parkville Australia

2. Department of Medical Biology The University of Melbourne Parkville Australia

3. Department of Medical Oncology Peter MacCallum Cancer Centre Melbourne Australia

4. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

5. Immunology Division The Walter and Eliza Hall Institute of Medical Research Parkville Australia

6. Personalised Oncology Division The Walter and Eliza Hall Institute of Medical Research Parkville Australia

7. Department of Pathology The Royal Melbourne Hospital Parkville Australia

8. Bioinformatics Division The Walter and Eliza Hall Institute of Medical Research Parkville Australia

9. School of Mathematics and Statistics The University of Melbourne Parkville Australia

10. Blood Cells and Blood Cancer Division The Walter and Eliza Hall Institute of Medical Research Parkville Australia

Funder

National Health and Medical Research Council

Cancer Council Victoria

Victorian Cancer Agency

Australian Cancer Research Foundation

Breast Cancer Research Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13179

Reference46 articles.

1. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

2. Cells of origin in cancer

3. Comprehensive molecular portraits of human breast tumours

4. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

5. Proteogenomics connects somatic mutations to signalling in breast cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CRISPR/Cas9 based therapy in breast cancer: a future direction;The Nucleus;2024-04

2. Combinatorialin vivogenome editing identifies widespread epistasis during lung tumorigenesis;2024-03-08

3. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09

4. Systemic and Local Strategies for Primary Prevention of Breast Cancer;Cancers;2024-01-05

5. Organoid Cultures for the Study of Mammary Biology and Breast Cancer: The Promise and Challenges;Cold Spring Harbor Perspectives in Medicine;2023-12-18